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Abstract: The immunohistochemistry technique is used in the search for cell or tissue antigens that range from amino acids and 
proteins to infectious agents and specific cellular populations. The technique comprises two phases: (1) slides preparation and stages 
involved for the reaction; (2) interpretation and quantification of the obtained expression. Immunohistochemistry is an important tool 
for scientific research and also a complementary technique for the elucidation of differential diagnoses which are not determinable by 
conventional analysis with hematoxylin and eosin. In the last couple of decades there has been an exponential increase in publications 
on immunohistochemistry and immunocytochemistry techniques. This review covers the immunohistochemistry technique; its history, 
applications,  importance,  limitations,  difficulties,  problems  and  some  aspects  related  to  results  interpretation  and  quantification. 
Future developments on the immunohistochemistry technique and its expression quantification should not be disseminated in two 
languages—that of the pathologist and another of clinician or surgeon. The scientific, diagnostic and prognostic applications of this 
methodology must be explored in a bid to benefit of patient. In order to achieve this goal a collaboration and pooling of knowledge from 
both of these valuable medical areas is vital
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The Immunohistochemistry 
Technique
The immunohistochemistry technique is used in the 
search for cell or tissue antigens ranging from amino 
acids  and  proteins  to  infectious  agents  and  specific 
cellular  populations.1  The  technique  comprises  two 
phases: (1) slide preparation (specimen fixation and 
tissue processing) and stages evolved for the reaction 
(in  order:  antigen  retrieval,  non-specific  site  block, 
endogenous peroxidase block, primary antibody incu-
bation, and the employment of systems of detection, 
revealing and counterstaining and also slide mounting 
and storage); (2) interpretation and quantification of the 
obtained expression.2
Immunohistochemistry  is  an  umbrella  term  that 
encompasses many methods used to determine tissue 
constituents (the antigens) with the employment of 
specific  antibodies  that  can  be  visualized  through 
staining.1,3 When used in cell preparations it is called 
immunocytochemistry, a term that some authors use 
for all methods entailing the immunological search of 
cell antigens, even when this involves tissue slices.
Brandtzaeg  stated  that  immunostaining  for  cell 
markers represents a way to “talk with cells”, because 
it allows not only the histological origin of the cell to 
be identified but also indicates its function in vivo, 
when duly investigated with the correct antibodies.1
The same author affirmed that it is lamentable and 
non-justifiable to classify immunohistochemistry as a 
merely descriptive method. He also emphasized that 
many reviewers, not aware of the accuracy of immu-
nological detection methods, may consider them an 
inferior research tool where many manuscripts are 
refused on these grounds. He concluded that in vitro 
and in situ trials are in fact “pictures” of the situations 
that occur in vivo and therefore constitute one of the 
pillars of biomedical research. This includes immuno-
histochemistry, the importance of which is growing.1
History
The history of immunostaining methods began when 
Marrack produced reagents against typhus and cholera 
microorganisms, using a red stain conjugated to benzidin 
tetraedro.4 However, Professor Albert H. Coons from 
Harvard School of Medicine—Boston, U.S.A. believed 
that the antigen detection provided by red color in tis-
sue slices had very low sensitivity under optical micros-
copy and, in the early nineteen forties demonstrated 
that localizing antigens, especially microorganisms, was 
possible in tissue slices using antibodies against Strep-
tococcus pneumoniae stained with fluorescein, visual-
ized by ultra-violet light (fluorescence microscopy).5
Subsequently,  the  introduction  of  enzymes  as 
marked antibodies, developed by Nakane, heralded 
a new and important era for immunohistochemistry, 
since it was possible to see these reactions through 
optical microscopy. These results had great impact 
and were much awaited in the nineteen sixties.6–8 
This innovation took immunohistochemistry beyond 
the exclusive sphere of laboratories equipped with 
fluorescence microscopes, and the technique spread 
to a broad group of researchers and pathologists.3
The following discoveries of the unlabelled antibody 
peroxidase-antiperoxidase (PAP) method by Sternberger 
et al9 and the alkaline phosphatase-antialkaline phospha-
tase (APAAP) method by Mason et al10,11 significantly 
expanded  the  application  of  immunohistochemistry 
technique.9,12 The diaminobenzidine molecule (DAB) 
was  also  conjugated  to  antibodies  during  the  same 
period,13 currently representing the most used chromo-
gen for peroxidase, and as it produces an electrodense 
precipitate which is also used in electronic microscopy, 
substituting ferritin.14 Subsequently, gold colloidal par-
ticles  were  introduced  as  immunohistochemical  col-
orations15 and this finding rapidly led to an important 
method of subcellular immunostaining.16
The discovery of antigen retrieval methods (expo-
sure of antigen epitopes present in study tissue, favor-
ing the antigen-antibody reactions for the next stages 
of the technique) by Huang et al,17 and also the sys-
tems of secondary antibody detection (for example 
the  avidin-biotin-peroxidase  complex—ABC  and 
the labeled streptavidin-biotin complex—LSAB) by 
Hsu et al18–21 allowed immunohistochemistry to be 
used in fresh specimens as well as in fixed tissues, 
which further increased the applicability of the tech-
nique  in  pathology  diagnostic  routines.  However, 
only after the presence of tissue antigens could be 
demonstrated  by  the  immunoperoxidase  technique 
in tissues fixed in formalin and embedded in paraf-
fin, did immunohistochemistry really became incor-
porated into the diagnostic routine of pathological 
anatomy.22–27
In the last couple of decades there have been an 
exponential increase in publications on immunohis-
tochemistry  and  immunocytochemistry  techniques Immunohistochemistry and biomarkers detection
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(Fig. 1). This literature is available in many cellular 
and molecular biology, biochemistry, pathology, his-
tology, immunology, internal medicine and surgery 
scientific articles.
This fact reflects the position that immunohisto-
chemistry currently holds in a pathological anatomy 
laboratory. It is an important tool for scientific research 
and also a complementary technique in the elucidation 
of  differential  diagnosis  which  are  not  determin-
able by conventional analysis with hematoxylin and 
eosin.2,22–24,26,28–37 The great improvement in the con-
tribution and application of immunohistochemistry in 
pathological anatomy became known as the “brown 
revolution” of the histopathology laboratory.22
Applications and importance
The immunohistochemical reactions can be used in 
different  situations  within  research  or  pathological 
anatomy laboratories. The most important are: 1) histo-
genetic diagnosis of morphologically non-differentiated 
neoplasias (Fig. 2); 2) subtyping of neoplasias (such 
as lymphomas, for example); 3) characterization of 
primary  site  of  malignant  neoplasias;  4)  research 
for prognostic factors and therapeutic indications of 
some diseases; 5) discrimination of benign versus the 
malign nature of certain cell proliferations (Fig. 3); 
identification of structures, organisms and materials 
secreted by cells.2,22,23,26,36,38
Werner and colleagues27evaluated the reason for 
employment and number of cases in which immu-
nohistochemistry aided the diagnosis of neoplasias 
and pseudo-neoplastic lesions. It was noted that from 
a total of 3,760 specimens, in 19% of cases immu-
nohistochemistry was used to determine prognostic 
factors  or  proliferative  indexes;  17%  of  cases  had 
the  purpose  of  identifying  microorganisms,  cells, 
structures or secreted materials; and 64% of cases had 
a diagnostic application. From the 835 cases of this 
latter category immunohistochemistry contributed in 
83% for specific diagnoses and decreased the number 
of  non-defined  diagnosis  by  12%.  In  5%  of  cases 
immunohistochemistry  did  not  aid  the  pathologist 
due  to  the  exiguity  of  some  samples,  presence  of 
extensive necrosis, or extreme non-differentiation of 
some neoplasias. Data present in the literature on this 
subject is rare, however this study corroborates the 
results  shown.22,30,32  They  therefore  concluded  that 
immunohistochemistry  is  a  helpful  complementary 
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Figure 1. Number of scientific publications using the immunohistochemistry technique, found on the Medline database, between 1960 and 2006. The plot 
indicates the frequency in which the term “immunohistochemistry” appears in the title or abstract of the manuscripts. (Adapted from Werner et al27).Matos et al
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diagnostic method in 95% of cases and contributes 
toward surgical and therapeutic conducts, with low 
cost and high benefit.27
Limitations, difficulties and problems
Although a relatively simple technique, immunohis-
tochemistry has some particularities and its outcome 
depends on many factors. The usefulness and contri-
bution of immunohistochemistry in solving problems 
in pathological anatomy is directly proportionate to 
the experience of the hands that perform the reactions 
and also the eyes that interpret the results.2,22,24,36,38 
Therefore,  even  though  very  simple  in  concept, 
immunostaining methods requires rigor of execution 
and may present significant bias. Hence, its outcomes 
must be interpreted with caution.
A recent review39 discusses the main bias that may 
follow the analysis of immunohistochemistry reactions. 
These  are  didactically  divided  into  reaction  bias 
(examples: specimen fixation, tissue processing, antigen 
retrieval and detection system) and interpretation bias 
(examples: selection of antibody panels, sensitivity of 
the chosen panel, choice of antibody types and clones, 
results and literature interpretation).
A wide variety of protocols for standardizing the 
immunohistochemistry technique are being proposed 
to  minimize  undesirable  effects.  The  Committee 
of  Quality  Control  in  Immunohistochemistry  of  the 
French Pathology Society published a report in 1997 
demonstrating that two of the main causes of diagnosis 
mistakes  in  immunohistochemistry  are  the  non-
employment of antigen retrieval techniques and the use 
of amplifying methods with low power. Other renowned 
international quality programs are the electronic data-
base Immunoquery (“Immunohistochemistry Literature 
Database Query System”) and the UK NEQAS quality 
program (“United Kingdom National External Quality 
Assessment Scheme for Immunocytochemistry”).40–42
The  acquisition,  handling,  fixation,  specimen 
delivery to the laboratory and antigen retrieval are 
Figure 2. Histogenetic diagnosis of neoplasias using immunohistochemistry technique. A) Expression of cytoqueratin AE1/AE3 in lung carcinosarcoma 
(IHC-peroxidase—X200); B) chromogranin expression in gastric neuroendocrine carcinoma (IHC-peroxidase—X100); c) HMB 45 immunostainning in 
murine melanoma (IHC-peroxidase—X400).
Figure 3. Heparanase expression in the diagnosis of broncopulmonar carcinoid tumors. Optical microscopy at X400 power: A) negative expression of 
heparanase (absence of staining—peroxidase—in cell’s cytoplasm) in bronchial mucosa not compromised by neoplasm; B) positive expression of hepa-
ranase (presence of cytoplasm full of peroxidase—brownish areas) in broncopulmonar carcinoid tumor. (Adapted from: de Matos et al87).Immunohistochemistry and biomarkers detection
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all critical factors. Fresh specimens that are inad-
vertently submitted to long periods of fixation may 
significant  lose  antigenicity.39,43  As  an  example, 
Jacobs and colleagues44 showed that there is progres-
sive loss of antigenicity upon only 12 week storage 
of breast cancer histological slices on slides stored 
in  ambient  temperature  for  the  detection  of  p53, 
Bcl-2,  estrogen  receptor  and  factor VIII  proteins. 
However, the same was not observed in recent his-
tological slices of specimens in paraffin blocks for 
periods of over 10 years.45 The specimen fixation in 
formaldehyde and its consequent inclusion in paraf-
fin are the internationally most used histological pro-
cessing procedures. Some specialists propose that 
this procedure should be the standard for comparing 
diagnostic outcomes among immunohistochemistry 
reactions.46 However, formaldehyde fixation results 
in  a  variably  reversible  loss  of  immunoreactivity 
by its masking or damaging some antibody binding 
sites.29 Although such epitopes may be demasked by 
several epitope retrieval methods, the immunohis-
tochemical detection system must still be sensitive 
enough to produce a strong signal. For some epitopes, 
the duration of the formaldehyde fixation is critical. 
With some antibodies, depending on the resistance 
of its target epitope to autolytic change, delay in fix-
ation may cause loss of immunoreactivity.47
Other  fixatives  often  used  in  pathology  include 
alcohol and alcohol-based fixatives such as acetone. 
Alves et al48 studied the fixation in ethanol and formalin 
for trypsin digestion in immunohistochemical detection 
of cytokeratins and vimentin in a case of ovarian cyst-
adenofibrocarcinoma. They found superior reactivity 
for both markers in achieved ethanol-fixed sections, 
even in samples stocked up to 60 days. Cytokeratin 
reaction in formalin-fixed sections was better when 
trypsin was used. However, this digestion was delete-
rious to vimentin detection. This was an import work 
to alert surgeons and oncologists on the relevance 
of  fixation  of  specimens  suspicious  for  neoplasia, 
since different epitopes may require different fixa-
tives and the inadequate choice in the operative room 
may impart difficulties when immunohistochemistry 
is necessary.
It is important to emphasize that in tissue processing, 
inclusion in paraffin at high temperatures (in general, 
over 60 °C) may compromise the specimen antigenicity. 
Another  important  point  addresses  the  preparation 
of slides. The block slices must preferentially present 
a thickness ranging between 3 and 7 µm and must 
be deposited on slides previously prepared with some 
kind of adhesive (the most used are silane and polyly-
sine). Slices less than 3 µm thick could result in very 
weak immunostaining while those thicker than 7 µm 
may lead to loss of tissue on the glass slide or may 
hamper analysis of the resultant immunostaining.39
The amount of material to be analyzed is being 
discussed, especially now that pathologists are expected 
to reach a precise diagnosis with small samples.2 In the 
majority of situations a block is sufficient, preferentially 
when it contains a fragment of the tumor-surrounding 
parenchyma interface (prepared in the macroscopic 
examination), distally to hemorrhagic or extensively 
necrotic areas, as well as a fragment representative of 
the tissue distal to the neoplasm.49 Whenever possible, 
tissue that was previously submitted for frozen exami-
nation must be avoided.2
Regarding antigen retrieval, the simplification of 
procedures, costs and technical error risk reduction 
are  important  factors.  Irradiation  techniques  with 
microwaves or by humid heat in pressure or vapor 
pan, with exposition times adapted to offer the same 
pattern of staining in a group of case-controls has 
been suggested.2,50,51
The use of detection systems (secondary antibodies) 
is also considered valuable in error reduction.52 Among 
high  discharge  amplification  systems,  the  avidin-
biotin-peroxidase  complex  (ABC)  and  the  labeled 
streptavidin-biotin  complex  (LSAB)  are  the  most 
important.53–56  Specific  situations  require  adaptations 
and even the use of alternative detection methods.
The selection of an adequate method is one of the 
great technical responsibilities faced in an immuno-
histochemistry laboratory. The advance in the tech-
nique, with systems of epitope retrieval through heat 
(HIER)  and  amplification  methods,  as  well  as  the 
reactions performed in a single stage (EPOS)57 and the 
method of catalyzed product deposition (CARD),58,59 
have introduced a paradox in immunohistochemistry. 
On the one hand numerous cases hitherto unsolved 
because of negativity in many panels, became positive 
and began to permit precise diagnosis. On the other 
hand, antibodies that were expressed characteristically 
in certain neoplasias began to react non-specifically 
in other situations.2,25 Concerned about the so called 
“anarchy” then introduced, Swanson25 proposed that Matos et al
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no  method  should  be  universally  applicable,  the 
choice should be based on the technique that, in the 
experience of the laboratory or of the school followed 
by researchers, best solves the diagnostic question.2
Due  to  their  flexibility  and  relatively  low  cost, 
the most used protocols currently (such as the ABC 
method, for example) are indirect and therefore require 
many  stages  of  incubation.  High  sensitivity  could 
be obtained with the application of immunological 
principles, enzymatic amplification reactions and/or 
the employment of avidin-biotin complex, however 
the various steps required must be rigorously followed 
in  order  to  avoid  non-desirable  interactions.  It  is 
fundamental that, on technical planning, all reagents 
follow the sequence rigorously established, where the 
employment of work flow charts for such stages are 
very useful in avoiding false results. Making notes 
of all reaction stages and pattern of each antibody 
are equally important and are suggested in patterning 
technique programs.2
The ability of the specialized technician who per-
forms the reactions is a guarantee against the intro-
duction  of  crossed  immunological  reactions  with 
endogenous immunoglobulins during the test prepa-
rations,  or  with  different  sequence  experiments  of 
immunostaining with many colors.1
The  selection  of  antibody  panels  is  one  of  the 
most important aspects for optimal applicability of 
immunohistochemistry.2  Studies  from  Jensen  and 
colleagues60,61 concluded that the selection of the anti-
body panel and the interpretation of the reaction pat-
terns of each case were the most important factors for 
the final diagnostic outcome.60 This observation was 
fundamental because the detection sensitivity of the 
chosen panel evidently increases with increased prac-
tice and experience of the pathologist who indicates 
the method, combined with the clinical data analy-
sis  by  the  researchers.39  Prescott  and  colleagues62 
attributed 42.1% of the diagnostic discrepancies in 
immunohistochemistry to poor antibody selection.
The knowledge of each reagents’ characteristics, 
especially those of antibodies, requires new titration 
in  each  new  batch  or  clone,  selecting  the  dilution 
that offers the greatest “true/background positivity” 
contrast.2,39
The primary antibodies can be divided into two 
categories:  poly  or  monoclonal.  The  polyclonal 
group are those obtained from animal immunization 
(example: rabbit, goat, monkey, rat, mouse, ewe etc) 
and results in antibodies that are capable of recog-
nizing many epitopes of the same antigen, generat-
ing higher detection sensitivity. The monoclonal type, 
however,  are  developed  from  hybrids  and  provide 
antibodies against only one antigen epitope, yielding 
more specific results.1,28,63
Regarding  the  validation  of  findings  and  their 
interpretation, it is necessary to observe the reactivity 
patterns  of  the  negative  and  positive,  internal  and 
external controls. The external controls (histological 
slices of specific tissues for each antibody) must be 
included in each panel, prepared from the samples 
fixed under the same conditions as the test cases and 
submitted to the same stages of the reaction. Attention 
must also be paid to the reactivity of structures present 
on the slide of the case being studied that may be used 
as internal positive controls, such as the reactivity of 
vessels for vimentin, muscle and endothelial markers, 
or breast ducts adjacent to the neoplasm for estrogen 
and  progesterone  receptors.  Similarly,  structures 
knowingly negative for a marker offer an excellent 
internal negative control, since they were submitted 
to the same treatment as the test-tissue, for example 
the  erythrocytes  within  blood  vessels—a  great 
endogenous source of peroxidase.2,23,56,64,65
Interpretation of Immunohistochemistry 
expression
The interpretation of immunohistochemistry expres-
sion is generally made in a qualitative and subjective 
manner, whereas quantification is considered of little 
or no importance.66 Frequently, a diagnostic decision 
is based on cellular presence or absence of a particu-
lar molecule.67
Nowadays, an increasing cause of contradictory 
results in the literature is the lack of a definition on what 
constituted a positive result. In the majority of spe-
cialized studies,66 a result known as “positive” refers 
simply to the presence of brown staining (peroxidase) 
in any part of the studied tissue. Some authors how-
ever, extrapolate this definition and consider it a wider 
concept, leading to confounding factors. An example 
of this dilemma is the interpretation of S-100 protein 
expression that, for some authors, must be nuclear and 
cytoplasmic, while for others the staining of only the 
cytoplasm is sufficient to consider the immunoexpres-
sion positive.68 In a similar manner, studies with the Immunohistochemistry and biomarkers detection
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HER2 protein where positive cases can include those 
in which the staining was exclusively cytoplasmic.69–72 
However it is known that only the cases with stain-
ing for the cellular membrane are associated to the 
amplification of its gene as determined by molecular 
methods of detection.73 The answer to this question is 
to consider as positive the slide that presents brown 
staining  (positive)  and  to  then  analyze  the  expres-
sion of the target-molecule in a clinical-morphologic 
context. The immunoexpression in different cellular 
compartments or in extra-cellular matrix components 
of the same marker can indicate that it is perform-
ing distinct or even opposite biological functions. It is 
fundamental, for the correct interpretation of a immu-
nohistochemistry expression, to know the functions 
and the biological phenomena in which the studied 
molecule is involved and, based on this knowledge, 
the real clinical relevance of this immunoexpression 
can be defined.74
There is a rule that tries to avoid some of these 
problems: when the location of a target-molecule is 
known, the immunoreactivity pattern must follow the 
micro-anatomic or subcellular (cellular compartment) 
distribution of the antigen.66 For example, a granular 
intra-cytoplasmatic pattern should be observed when 
antibodies  that  detect  molecules  contained  in  cyto-
plasmatic vesicles (examples: chromogranin, von Wil-
lebrand factor, HMB-45) are employed.2 In this way, 
when the staining of an antibody, whose function is well 
documented and known, does not manifest as expected 
many authors consider it a false-positive result.48 How-
ever, it is important to emphasize that the researcher can 
be confronted with another biological function of the 
studied molecule, as yet undescribed.
The validation of results in cases of ambiguity can 
be solved using antibodies against different epitopes 
of the same molecule, or by the detection of correlated 
antibodies (for example, synaptophysin and chromo-
granin are both frequently expressed in neuroendo-
crine tumors).2,66
However, when the nature of an antigen or its function 
has not yet been totally elucidated, determining if the 
positivity of a given immunohistochemistry expres-
sion is relevant could prove hard.66 The possibility 
exists of a false-positive result, but also that the cell in 
question plays distinct biological roles depending on 
the cellular compartment where the immunostaining 
is present.
The  interpretation  of  immunostaining  depends 
on the quantity of antigen present in the tissue and 
according to some authors,66,75 on the determination 
of cut off values between what must be considered as 
positive and negative results, although it is important 
to  emphasize  that  this  quantifying  methodology 
is  not  adequate.  These  values  are  often  arbitrarily 
determined, not obtained by other laboratories and 
its intra-laboratory reproducibility has frequently not 
yet been tested.66 Among all these reasons, certainly 
the inter-laboratory reproducibility of the results of 
immunohistochemistry reactions is one of the most 
difficult challenges faced.66,75
In order to minimize these discrepancies, Seidal and 
colleagues66 suggest that more accurate quantifying 
methods should be adopted and studies encouraged 
that are dedicated to developing and refining them.
Quantification of 
Immunohistochemistry expression
Soon after the introduction of immunohistochemistry 
as a routine technique in pathology laboratories, efforts 
were made in order to try quantify protein expression 
using immunohistochemistry.76–78 Many studies have 
demonstrated that there is a correlation between the 
results obtained from the immunohistochemistry quan-
tification and the tissue concentration of the antigen in 
question.64,79,80
The biological colorations (which includes those 
performed  with  aniline,  hematoxylin  and/or  eosin 
for example) are usually difficult to control in terms 
of  staining  intensity.  This  makes  the  comparison 
from cell to cell difficult as well as from slide to 
slide (between different tissues and between slides 
prepared on different days). This difficulty tends to 
decrease  with  the  introduction  of  automatic  tech-
niques of coloration.81
The reagents employed in the immunohistochemistry 
technique present the potential to give true quantitative 
results. Most researchers, however, do not consider 
this possibility because they often do not observe the 
fact that this technique is no more than an immunolog-
ical test carried out in situ or in histological slices. The 
obtained staining by the immunohistochemistry tech-
nique is analogous to the results obtained in an ELISA 
test (enzyme-linked immunosorbent assay), a method 
recognized worldwide as truly quantitative. Exactly 
the same reagents that are applied in a serum test of Matos et al
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ELISA can be employed for immunohistochemistry 
reactions in histological slices of specimens in paraf-
fin blocks. Nevertheless, it is curious that the appli-
cation  of  the  same  immunological  principles  and 
reagents  are  accepted  as  truly  quantitative  in  the 
ELISA test, but when applied in histological slices 
(immunohistochemistry)  are  called  merely  “stain-
ing”.81 The statistically significant correlation between 
the result from the quantification of the immunohisto-
chemistry reaction and protein levels have been dem-
onstrated  through  various  measurement  methods,82 
including Western blotting83–87 and immunoenzymatic 
methods.88–91
As the need for an accurate immunostaining mea-
surement is rising, quantitative biochemical methods 
of tissue detection are being progressively substituted 
by immunohistochemistry.66 Some question whether 
this precision is in fact achievable, or even neces-
sary. However, advances in molecular biology and the 
emergence of new treatments for cancer will certainly 
increase the demand for precise results of a series of 
new molecules or target-genes, as a patient selection 
method for a given treatment. An example that already 
exists is the use of trastuzumabe in patients with breast 
carcinoma that presents 3+ or greater immunostaining 
for the HER2 oncogene.92 Therefore, studies will be 
developed in a progressively higher number of tissues, 
because the immunohistochemistry will likely be the 
chosen tool in the detection of these molecules.
Many  semi-quantitative  measurement  methods 
of  immunohistochemistry  reactions  based  on  visual 
scores have been proposed in an attempt to improve this 
quantification.93,94 However, image analysis assisted by 
computer is proving superior compared to visual esti-
mates in the establishment of quantitative results of 
immunohistochemistry reactions.95
Semi-quantitative analysis
As seen previously, the tissue expression of biomark-
ers  employed  in  the  immunohistochemistry  tech-
nique can occur in different cellular compartments 
and even in extra-cellular matrix constituents.66,96 The 
evaluation of this reactivity may vary from essen-
tially positive or negative to immunostaining inten-
sity and/or extension,96 which constitutes an attempt 
towards immunohistochemistry technique quantifica-
tion, frequently denoted in the literature as a “semi-
quantitative method”.
When  the  intensity  is  the  evaluation  focus,  the 
inclusion  of  reaction  controls  containing  different 
levels of staining are required for comparing criteria. 
Subjective scores, such as those that categorize the 
reaction in groups of null, weak, moderate and intense 
immunostaining, depend very much on the researcher’s 
experience and are therefore unsuitable.66,96
To estimate the extension of immunostaining can 
also vary from a meticulous counting to a “glance” 
over the slides.96 The evaluation of the percentage of 
labeled cells trough the categorization of scores of 
the obtained percentage are less precise. Examples 
of the employment of this methodology includes the 
count of micro-metastases in bone marrow samples 
or the measurement of peritumoral blood vessels. In 
these examples minimal variances of immunoreac-
tivity intensity, attributed to the staining method or 
to the fixation procedure, have little impact on the 
quantification itself. A similar attempt of quantifica-
tion can be exemplified by the estimate of the pro-
liferation  index  through  immunostaining  by  Ki67 
(MIB-1), or by factors related to the cellular cycle 
such as P53 and P21, in which a simple count leads 
to the quantity of normal and neoplastic cells. Such 
methods demonstrate low reproducibility and consis-
tency of results in terms of cut off values with rel-
evant sensitivity.66
Score systems were introduced to clinical practice 
in an attempt to overcome variances, particularly for 
markers that aim to select patients for specific treat-
ments. It is important to emphasize that all scores, 
including those mainly used in daily practice, have 
demonstrated statistically significant relevance with 
regards to clinical variables when used by experienced 
researchers in the area, although they are laborious 
and fatiguing.
Computer-assisted quantitative analysis
The computer-assisted image analysis has been in use 
since the 1980s,97,98 without a well defined historical 
sequence,  and  has  proved  superior  to  the  semi-
quantitative method, especially in terms of its quan-
tification accuracy in many kinds of markers,82,89,99–123 
representing the solution for the reproducibility and 
applicability of the semi-quantitative score systems, 
because  it  yields  itself  to  the  desired  quantitative 
result.83 Comparative studies demonstrate that, in con-
trolled circumstances, the system of image analysis Immunohistochemistry and biomarkers detection
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was superior to the manual methods when performed 
by many observers.117,124–126
Perspectives
The future perspectives point to new discoveries that 
should make the immunostaining methods simpler. An 
already available example was the introduction of the 
reactions performed in a single stage (EPOS).127 This 
involves an inert polymer in which many molecules from 
the primary antibody and peroxidase are chemically 
connected,  consequently  decreasing  the  number  of 
incubation stages, and is currently commercially avail-
able. Other important achievements were the develop-
ment of semi-automatic machines especially devised 
for  the  immunohistochemistry  technique128  and  the 
microarray technology that will be fundamental in the 
selection of proteins implicated in diagnosis, prognosis 
and therapeutic decisions of many diseases.129 Despite 
its high cost, this type of technology could be funda-
mental to pathology laboratories in which the diagnostic 
routine is very extensive. In addition it could also be of 
great value in the standardization of the employed tech-
nique and the reproducibility of the results.1
Without doubt, the development of quantification 
methods  for  the  immunohistochemistry  technique, 
mainly  those  which  are  computer-assisted,  have 
increased not only the accuracy in the detection of 
markers, but also the reliability of their results. Most 
larger laboratories, until recently, were those which 
held this technology compared to small laboratories 
and academic centers, largely due to economic rea-
sons.81,130 However, with the recent spread, practical-
ity, reproducibility and reliability of obtained results 
along  with  falling  costs  of  systems  of  computer-
assisted image analysis is changing this panorama. 
At present, immunohistochemistry quantification is 
widely employed in many areas, not only in pathol-
ogy, but also in various medical areas with particular 
impact in the clinical daily practice.
Future developments of the immunohistochemistry 
technique and its expression quantification should not 
be disseminated in two languages—that of the pathol-
ogist and that of the clinician or surgeon. The scien-
tific, diagnostic and prognostic applications of this 
methodology must be explored in a bid to benefit of 
patient. In order to achieve this goal the collaboration 
and pooling of knowledge between these two valu-
able medical areas is vital.
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